Results 211 to 220 of about 75,243 (298)

Silicosis, Sarcoidosis, and Silicosarcoidosis Are Overlapping Diagnoses and Difficult to Differentiate

American Journal of Industrial Medicine, Volume 69, Issue 5, Page 313-322, May 2026.
ABSTRACT We evaluated 12 workers with documented exposure to respirable crystalline silica who were referred to a tertiary care center due to clinical suspicion of silicosis, sarcoidosis, or silicosarcoidosis. Although silica exposure is a well‐established risk factor for silicosis and has been associated with autoimmune diseases, mycobacterial ...
Guilherme Ward Leite, Eduardo Kaiser Ururahy Nunes Fonseca, Rodrigo Caruso Chate, Lavinia Clara Del Roio, Sofia de Paiva Memento Machado, Jefferson Benedito de Freitas, Ronaldo Adib Kairalla, Mário Terra‐Filho, Ubiratan Paula Santos, Rafael Futoshi Mizutani   +9 more
wiley   +1 more source

Postpartum-Onset Dermatomyositis Presenting With Malignant Pleural Effusion: A Case Report. [PDF]

Cureus
Zainab E, Aslam HG, Atif A, Imran M.
europepmc   +1 more source

Immune‐Related Polyradiculoneuropathy Associated With Immune Checkpoint Inhibitors: A Comprehensive Case Series

Brain and Behavior, Volume 16, Issue 5, May 2026.
ABSTRACT Objective Immune‐related polyradiculoneuropathy (irPRN) is a rare but potentially severe neurological adverse event secondary to immune checkpoint inhibitors (ICIs), closely resembling Guillain–Barré syndrome. This study aims to characterize the clinical presentation, neurophysiological findings, therapeutic strategies, and clinical outcomes ...
A. Llauradó, E. Lainez, H. Ariño, M. Gratacòs‐Viñola, J. L. Seoane, M. Roca‐Herrera, J. L. Restrepo‐Vera, D. Sanchez‐Tejerina, N. Raguer, R. Juntas‐Morales   +9 more
wiley   +1 more source

Myoepithelioma of the Lung: A Rare Case With Bilateral Pleural Spread and Diagnostic Challenges in a Middle-Aged Female. [PDF]

Cureus
Mahajan M, Seth M, Seth M, Nikhra P, Gupta K, Nain S.   +5 more
europepmc   +1 more source

Age‐Associated Targetable Genomic Alterations and PD‐L1 Expression in 2509 Patients With Pulmonary Ground‐Glass Opacities

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Aim To investigate the landscape of targetable genomic alterations and programmed cell death ligand 1 (PD‐L1) expression in pulmonary ground‐glass opacities (GGOs) and their association with age. Methods A total of 2509 patients with GGOs were retrospectively analyzed.
Wen‐Fang Tang, Si‐Qi Huang, Yi‐Duo Lin, Hong‐Ji Li, Qing‐Hua Huang, Jing Chen, Zhen‐Bin Qiu, Wei‐Zhao Huang, Ying‐Meng Wu, Hong‐Yu Ye, Wei Xu, Xue‐Ning Yang, Yi‐Long Wu, Hai‐Ming Jiang, Yi Liang, Xuan Tang, Wen‐Zhao Zhong   +16 more
wiley   +1 more source

Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review. [PDF]

Eur Respir Rev
Hajja A, Atout M, Turko R, Syed H, Duarte D'Ambrosio P, Terra RM, Abdulhaq A, Nardini M, Ambrogi MC, Lucchi M, Robaidi H, Saleh W, AlKattan K, Migliore M.   +13 more
europepmc   +1 more source

Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Ovarian Cancer (OC), the deadliest gynecological malignancy, poses a major therapeutic challenge in advanced stages owing to its high recurrence rate and metastatic potential. In this regard, it is noteworthy that immunotherapy has recently gained significant attention in OC treatment, a phenomenon attributable to notable advances in over‐the ...
Liying Wang, Yisen Cao, Yuan Ren, Yuhang Zhang, Liang Wang   +4 more
wiley   +1 more source

Case Report: A case of ovarian carcinoma manifesting with chest tightness as the initial clinical presentation accompanied by marked elevation of pleural effusion amylase levels. [PDF]

Front Oncol
Ou GY, Zhu YC, Li K, Li CJ, Yi X, Wan QB, Shen HL.   +6 more
europepmc   +1 more source

Pertuzumab Vs. Pyrotinib in Combination With Trastuzumab and Taxanes for First‐Line Treatment of HER2+ MBC: A Multicenter Real‐World Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Taxanes combined with trastuzumab plus either pertuzumab (THP) or pyrotinib (THPy) are standard first‐line treatments for HER2‐positive metastatic breast cancer (HER2+ MBC). Nevertheless, direct comparative evidence remains insufficient. This study compared the efficacy and safety of THP vs. THPy for HER2+ MBC.
Meiqiong Kuang, Jianbin Li, Li Bian, Shaohua Zhang, Tao Wang, Zhongsheng Tong, Quchang Ouyang, Zefei Jiang   +7 more
wiley   +1 more source

Synchronous Extensive-Stage Small Cell Lung Cancer and Multiple Myeloma Detected by Marked Hypergammaglobulinemia. [PDF]

Cureus
Fujimoto M, Yanagihara T, Ueno H, Aoki M, Hamasaki M, Isobe Y, Ebi N, Inoue H, Fujita M.   +8 more
europepmc   +1 more source